Natural Products. Biosynthesis
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Retention Indices for Frequently Reported Compounds of Plant Essential Oils
Retention Indices for Frequently Reported Compounds of Plant Essential Oils V. I. Babushok,a) P. J. Linstrom, and I. G. Zenkevichb) National Institute of Standards and Technology, Gaithersburg, Maryland 20899, USA (Received 1 August 2011; accepted 27 September 2011; published online 29 November 2011) Gas chromatographic retention indices were evaluated for 505 frequently reported plant essential oil components using a large retention index database. Retention data are presented for three types of commonly used stationary phases: dimethyl silicone (nonpolar), dimethyl sili- cone with 5% phenyl groups (slightly polar), and polyethylene glycol (polar) stationary phases. The evaluations are based on the treatment of multiple measurements with the number of data records ranging from about 5 to 800 per compound. Data analysis was limited to temperature programmed conditions. The data reported include the average and median values of retention index with standard deviations and confidence intervals. VC 2011 by the U.S. Secretary of Commerce on behalf of the United States. All rights reserved. [doi:10.1063/1.3653552] Key words: essential oils; gas chromatography; Kova´ts indices; linear indices; retention indices; identification; flavor; olfaction. CONTENTS 1. Introduction The practical applications of plant essential oils are very 1. Introduction................................ 1 diverse. They are used for the production of food, drugs, per- fumes, aromatherapy, and many other applications.1–4 The 2. Retention Indices ........................... 2 need for identification of essential oil components ranges 3. Retention Data Presentation and Discussion . 2 from product quality control to basic research. The identifi- 4. Summary.................................. 45 cation of unknown compounds remains a complex problem, in spite of great progress made in analytical techniques over 5. -
Poxviruses: Smallpox Vaccine, Its Complications and Chemotherapy
Virus Adaptation and Treatment Dovepress open access to scientific and medical research Open Access Full Text Article R E V IEW Poxviruses: smallpox vaccine, its complications and chemotherapy Mimi Remichkova Abstract: The threat of bioterrorism in the recent years has once again posed to mankind the unresolved problems of contagious diseases, well forgotten in the past. Smallpox (variola) is Department of Pathogenic Bacteria, The Stephan Angeloff Institute among the most dangerous and highly contagious viral infections affecting humans. The last of Microbiology, Bulgarian Academy natural case in Somalia marked the end of a successful World Health Organization campaign of Sciences, Sofia, Bulgaria for smallpox eradication by vaccination on worldwide scale. Smallpox virus still exists today in some laboratories, specially designated for that purpose. The contemporary response in the treatment of the post-vaccine complications, which would occur upon enforcing new programs for mass-scale smallpox immunization, includes application of effective chemotherapeutics and their combinations. The goals are to provide the highest possible level of protection and safety of For personal use only. the population in case of eventual terrorist attack. This review describes the characteristic features of the poxviruses, smallpox vaccination, its adverse reactions, and poxvirus chemotherapy. Keywords: poxvirus, smallpox vaccine, post vaccine complications, inhibitors Characteristics of poxviruses Smallpox (variola) infection is caused by the smallpox virus. This virus belongs to the genus of Orthopoxvirus included in the Poxviridae family. Poxviruses are one of the largest and most complexly structured viruses, known so far. The genome of poxviruses consists of a linear two-chained DNA and its replication takes place in the cytoplasm of the infected cell. -
PRODUCT INFORMATION Geranyl Pyrophosphate (Triammonium Salt) Item No
PRODUCT INFORMATION Geranyl Pyrophosphate (triammonium salt) Item No. 63320 CAS Registry No.: 116057-55-7 Formal Name: 3E,7-dimethyl-2,6-octadienyl- diphosphoric acid, triammonium salt Synonyms: GDP, Geranyl Diphosphate, GPP MF: C10H20O7P2 · 3NH3 FW: 365.3 O O Purity: ≥90% (NH +) – O P O P O Supplied as: A solution in methanol 4 3 Storage: -20°C O– O– Stability: ≥2 years Information represents the product specifications. Batch specific analytical results are provided on each certificate of analysis. Laboratory Procedures Geranyl pyrophosphate (triammonium salt) is supplied as a solution in methanol. To change the solvent, simply evaporate the methanol under a gentle stream of nitrogen and immediately add the solvent of choice. A stock solution may be made by dissoving the geranyl pyrophosphate (triammonium salt) in the solvent of choice. Geranyl pyrophosphate (triammonium salt) is slightly soluble in water. Description Geranyl pyrophosphate is an intermediate in the mevalonate pathway. It is formed from dimethylallyl pyrophosphate (DMAPP; Item No. 63180) and isopentenyl pyrophosphate by geranyl pyrophosphate synthase.1 Geranyl pyrophosphate is used in the biosynthesis of farnesyl pyrophosphate (Item No. 63250), geranylgeranyl pyrophosphate (Item No. 63330), cholesterol, terpenes, and terpenoids. Reference 1. Dorsey, J.K., Dorsey, J.A. and Porter, J.W. The purification and properties of pig liver geranyl pyrophosphate synthetase. J. Biol. Chem. 241(22), 5353-5360 (1966). WARNING CAYMAN CHEMICAL THIS PRODUCT IS FOR RESEARCH ONLY - NOT FOR HUMAN OR VETERINARY DIAGNOSTIC OR THERAPEUTIC USE. 1180 EAST ELLSWORTH RD SAFETY DATA ANN ARBOR, MI 48108 · USA This material should be considered hazardous until further information becomes available. -
Lanosterol 14Α-Demethylase (CYP51)
463 Lanosterol 14-demethylase (CYP51), NADPH–cytochrome P450 reductase and squalene synthase in spermatogenesis: late spermatids of the rat express proteins needed to synthesize follicular fluid meiosis activating sterol G Majdicˇ, M Parvinen1, A Bellamine2, H J Harwood Jr3, WWKu3, M R Waterman2 and D Rozman4 Veterinary Faculty, Clinic of Reproduction, Cesta v Mestni log 47a, 1000 Ljubljana, Slovenia 1Institute of Biomedicine, Department of Anatomy, University of Turku, Kiinamyllynkatu 10, FIN-20520 Turku, Finland 2Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232–0146, USA 3Pfizer Central Research, Department of Metabolic Diseases, Box No. 0438, Eastern Point Road, Groton, Connecticut 06340, USA 4Institute of Biochemistry, Medical Center for Molecular Biology, Medical Faculty University of Ljubljana, Vrazov trg 2, SI-1000 Ljubljana, Slovenia (Requests for offprints should be addressed to D Rozman; Email: [email protected]) (G Majdicˇ is now at Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas 75235–8857, USA) Abstract Lanosterol 14-demethylase (CYP51) is a cytochrome detected in step 3–19 spermatids, with large amounts in P450 enzyme involved primarily in cholesterol biosynthe- the cytoplasm/residual bodies of step 19 spermatids, where sis. CYP51 in the presence of NADPH–cytochrome P450 P450 reductase was also observed. Squalene synthase was reductase converts lanosterol to follicular fluid meiosis immunodetected in step 2–15 spermatids of the rat, activating sterol (FF-MAS), an intermediate of cholesterol indicating that squalene synthase and CYP51 proteins are biosynthesis which accumulates in gonads and has an not equally expressed in same stages of spermatogenesis. additional function as oocyte meiosis-activating substance. -
IJCB 42B(1) 166-172.Pdf
Indian Journal of Chemistry Vol. 42B, January 2003, pp. 166-172 Synthesis and biological activity of 16-arylidene derivatives of estrone and estrone methyl ether Maninder Minu* & Dharam Paul lindal University In 5titutc of Pharmaceutical Sciences, Panjab University, Chandigarh 160014, India and G Leclercq & M Borras institut Jules Bordet, Association Hospitaliere de Bruxelles. Centre des Tumeurs de I'ULB, Rue Heger-Bordet 1- 1000, Belgiulll Received 24 April 200 I .. accepted (revised) 20 March 2002 The synthesis of 16-arylidene derivatives 3, 4, S, 6, 7. 8. 9, 10, 11, 12, 13, 14 and IS is described. These compounds have been tested at NCI, Bethesda, for their antineoplastic acti vity against the cell panel consisting of 60-ce!l lines and th e compounds 3, 4, S, 6 and 7 have also been tested for their ill vitro estrogenic / antiestrogenic activity; induction of ERE dependent luciferase inductio n was measured (MvLN celis). The formation of active steroids by aromatase has It was conceived that selective inhibitors of aroma been considered to play an important role in the de tase might be useful as a pharmacological tool to de velopment of human breast carcinoma t, at least one vice successful treatment approach for the hormonal third of all breast cancers establishing that. the estro dependent breast cancer. Our efforts were focused on gen-dependent carcinoma regresses following estro designing estrogen and estrogen methyl ether deriva 2 gen deprivation . In the postmenopausal women, the tives that might inhibit or possess antiestrogenic activ production of estrogen takes place in peripheral tissue ity. From these efforts, several 16-arylidine deriva 3 from inactive precursors by the action of aromatase . -
Suspect and Target Screening of Natural Toxins in the Ter River Catchment Area in NE Spain and Prioritisation by Their Toxicity
toxins Article Suspect and Target Screening of Natural Toxins in the Ter River Catchment Area in NE Spain and Prioritisation by Their Toxicity Massimo Picardo 1 , Oscar Núñez 2,3 and Marinella Farré 1,* 1 Department of Environmental Chemistry, IDAEA-CSIC, 08034 Barcelona, Spain; [email protected] 2 Department of Chemical Engineering and Analytical Chemistry, University of Barcelona, 08034 Barcelona, Spain; [email protected] 3 Serra Húnter Professor, Generalitat de Catalunya, 08034 Barcelona, Spain * Correspondence: [email protected] Received: 5 October 2020; Accepted: 26 November 2020; Published: 28 November 2020 Abstract: This study presents the application of a suspect screening approach to screen a wide range of natural toxins, including mycotoxins, bacterial toxins, and plant toxins, in surface waters. The method is based on a generic solid-phase extraction procedure, using three sorbent phases in two cartridges that are connected in series, hence covering a wide range of polarities, followed by liquid chromatography coupled to high-resolution mass spectrometry. The acquisition was performed in the full-scan and data-dependent modes while working under positive and negative ionisation conditions. This method was applied in order to assess the natural toxins in the Ter River water reservoirs, which are used to produce drinking water for Barcelona city (Spain). The study was carried out during a period of seven months, covering the expected prior, during, and post-peak blooming periods of the natural toxins. Fifty-three (53) compounds were tentatively identified, and nine of these were confirmed and quantified. Phytotoxins were identified as the most frequent group of natural toxins in the water, particularly the alkaloids group. -
Effect of Alkali Carbonate/Bicarbonate on Citral Hydrogenation Over Pd/Carbon Molecular Sieves Catalysts in Aqueous Media
Modern Research in Catalysis, 2016, 5, 1-10 Published Online January 2016 in SciRes. http://www.scirp.org/journal/mrc http://dx.doi.org/10.4236/mrc.2016.51001 Effect of Alkali Carbonate/Bicarbonate on Citral Hydrogenation over Pd/Carbon Molecular Sieves Catalysts in Aqueous Media Racharla Krishna, Chowdam Ramakrishna, Keshav Soni, Thakkallapalli Gopi, Gujarathi Swetha, Bijendra Saini, S. Chandra Shekar* Defense R & D Establishment, Gwalior, India Received 18 November 2015; accepted 5 January 2016; published 8 January 2016 Copyright © 2016 by authors and Scientific Research Publishing Inc. This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/ Abstract The efficient citral hydrogenation was achieved in aqueous media using Pd/CMS and alkali addi- tives like K2CO3. The alkali concentrations, reaction temperature and the Pd metal content were optimized to enhance the citral hydrogenation under aqueous media. In the absence of alkali, ci- tral hydrogenation was low and addition of alkali promoted to ~92% hydrogenation without re- duction in the selectivity to citronellal. The alkali addition appears to be altered the palladium sites. The pore size distribution reveals that the pore size of these catalysts is in the range of 0.96 to 0.7 nm. The palladium active sites are also quite uniform based on the TPR data. The catalytic parameters are correlated well with the activity data. *Corresponding author. How to cite this paper: Krishna, R., Ramakrishna, C., Soni, K., Gopi, T., Swetha, G., Saini, B. and Shekar, S.C. (2016) Effect of Alkali Carbonate/Bicarbonate on Citral Hydrogenation over Pd/Carbon Molecular Sieves Catalysts in Aqueous Media. -
Other Data Relevant to an Evaluation of Carcinogenicity and Its Mechanisms
WOOD DUST 173 3.5 Experimental data on wood shavings It has been suggested in several studies that cedar wood shavings, used as bedding for animaIs, are implicated in the prominent differences in the incidences of spontaneous liver and mammar tumours in mice, mainly of the C3H strain, maintained in different laboratories (Sabine et al., 1973; Sabine, 1975). Others (Heston, 1975) have attributed these variations in incidence to different conditions of animal maintenance, such as food consumption, infestation with ectoparasites and general condition of health, rather than to use of cedar shavings as bedding. Additional attempts to demonstrate carcinogenic properties of cedar shavings used as bedding materIal for mice of the C3H (Vlahakis, 1977) and SWJ/Jac (Jacobs & Dieter, 1978) strains were not successful. ln no ne of these studies were there control groups not exposed to cedar shavings. 4. Other Data Relevant to an Evaluation of Carcinogenicity and its Mechanisms 4.1 Deposition and clearance 4.1.1 Humans No studies of the deposition of wood dust in human airways were available to the Working Group. Particle deposition in the airways has been the object of several studies (for reviews, see Brain & Valberg, 1979; Warheit, 1989). Large particles (? 10 ¡.m) are almost entirely deposited in the nose; the deposition of smaUer particles depends on size but also on flow rates and type of breathing (mouth or nose); there is also inter-individual variation (Technical Committee of the Inhalation Specialty Section, Society of T oxicology, 1987). Particles deposited in the nasal airways are removed by mucociliary transport (for reviews, see Proctor, 1982; Warheit, 1989). -
Redalyc.Degradation of Citronellol, Citronellal and Citronellyl Acetate By
Electronic Journal of Biotechnology E-ISSN: 0717-3458 [email protected] Pontificia Universidad Católica de Valparaíso Chile Tozoni, Daniela; Zacaria, Jucimar; Vanderlinde, Regina; Longaray Delamare, Ana Paula; Echeverrigaray, Sergio Degradation of citronellol, citronellal and citronellyl acetate by Pseudomonas mendocina IBPse 105 Electronic Journal of Biotechnology, vol. 13, núm. 2, marzo, 2010, pp. 1-7 Pontificia Universidad Católica de Valparaíso Valparaíso, Chile Available in: http://www.redalyc.org/articulo.oa?id=173313806002 How to cite Complete issue Scientific Information System More information about this article Network of Scientific Journals from Latin America, the Caribbean, Spain and Portugal Journal's homepage in redalyc.org Non-profit academic project, developed under the open access initiative Electronic Journal of Biotechnology ISSN: 0717-3458 Vol.13 No.2, Issue of March 15, 2010 © 2010 by Pontificia Universidad Católica de Valparaíso -- Chile Received April 24, 2009 / Accepted November 6, 2009 DOI: 10.2225/vol13-issue2-fulltext-8 RESEARCH ARTICLE Degradation of citronellol, citronellal and citronellyl acetate by Pseudomonas mendocina IBPse 105 Daniela Tozoni Instituto de Biotecnologia Universidade de Caxias do Sul R. Francisco G. Vargas 1130 Caxias do Sul, RS, Brazil Jucimar Zacaria Instituto de Biotecnologia Universidade de Caxias do Sul R. Francisco G. Vargas 1130 Caxias do Sul, RS, Brazil Regina Vanderlinde Instituto de Biotecnologia Universidade de Caxias do Sul R. Francisco G. Vargas 1130 Caxias do Sul, RS, Brazil Ana Paula Longaray Delamare Universidade de Caxias do Sul R. Francisco G. Vargas 1130 Caxias do Sul, RS, Brazil Sergio Echeverrigaray* Universidade de Caxias do Sul R. Francisco G. Vargas 1130 Caxias do Sul, RS, Brazil E-mail: [email protected] Financial support: COREDES/FAPERGS, and D. -
Part I Biopharmaceuticals
1 Part I Biopharmaceuticals Translational Medicine: Molecular Pharmacology and Drug Discovery First Edition. Edited by Robert A. Meyers. © 2018 Wiley-VCH Verlag GmbH & Co. KGaA. Published 2018 by Wiley-VCH Verlag GmbH & Co. KGaA. 3 1 Analogs and Antagonists of Male Sex Hormones Robert W. Brueggemeier The Ohio State University, Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Columbus, Ohio 43210, USA 1Introduction6 2 Historical 6 3 Endogenous Male Sex Hormones 7 3.1 Occurrence and Physiological Roles 7 3.2 Biosynthesis 8 3.3 Absorption and Distribution 12 3.4 Metabolism 13 3.4.1 Reductive Metabolism 14 3.4.2 Oxidative Metabolism 17 3.5 Mechanism of Action 19 4 Synthetic Androgens 24 4.1 Current Drugs on the Market 24 4.2 Therapeutic Uses and Bioassays 25 4.3 Structure–Activity Relationships for Steroidal Androgens 26 4.3.1 Early Modifications 26 4.3.2 Methylated Derivatives 26 4.3.3 Ester Derivatives 27 4.3.4 Halo Derivatives 27 4.3.5 Other Androgen Derivatives 28 4.3.6 Summary of Structure–Activity Relationships of Steroidal Androgens 28 4.4 Nonsteroidal Androgens, Selective Androgen Receptor Modulators (SARMs) 30 4.5 Absorption, Distribution, and Metabolism 31 4.6 Toxicities 32 Translational Medicine: Molecular Pharmacology and Drug Discovery First Edition. Edited by Robert A. Meyers. © 2018 Wiley-VCH Verlag GmbH & Co. KGaA. Published 2018 by Wiley-VCH Verlag GmbH & Co. KGaA. 4 Analogs and Antagonists of Male Sex Hormones 5 Anabolic Agents 32 5.1 Current Drugs on the Market 32 5.2 Therapeutic Uses and Bioassays -
Titelei 1 1..14
XII Contents Contents Endorsement V Preface VII Chapter 1 Alkaloids 1 1.1 Nicotine from Tobacco 3 1.2 Caffeine from Green Tea and Green Coffee Beans 25 1.3 Theobromine from Cocoa Powder 39 1.4 Piperine from Black Pepper 53 1.5 Cytisine from Seeds of the Golden Chain Tree 65 1.6 Galanthamine from the Bulbs of Daffodils “Carlton” 83 1.7 Strychnine from Seeds of the Strychnine Tree 103 Chapter 2 Aromatic Compounds 129 2.1 Anethole from Ouzo, containing Anise Extract 131 2.2 Eugenol from Cloves 143 2.3 Chamazulene from German Chamomile Flowers 153 2.4 Tetrahydrocannabinol from Marijuana 169 Chapter 3 Dyestuffs and Coloured Compounds 189 3.1 Lawsone from Henna Leaves Powder 191 3.2 Curcumin from Turmeric 207 3.3 Brazileine from Pernambuco Wood 221 3.4 Indigo from Woad 241 3.5 Capsanthin from Sweet Pepper Powder 261 Chapter 4 Carbohydrates 283 4.1 Glucosamine from the shells of common shrimps 285 4.2 Lactose from Milk 303 4.3 Amygdalin from Bitter Almonds 319 4.4 Hesperidin from the Peel of Mandarin Oranges 335 Contents XIII Chapter 5 Terpenoids 357 5.1 Limonene from Brasilian Sweet Orange Oil 359 5.2 Menthol from Japanese Peppermint Oil 373 5.3 The Thujones from Common Sage or Wormwood 389 5.4 Patchouli Alcohol from Patchouli 409 5.5 Onocerin from Spiny Restharrow Roots 427 5.6 Cnicin from Blessed Thistle Leaves 443 5.7 Abietic Acid from Colophony of Pine Trees 459 5.8 Betulinic Acid from Plane-Tree Bark 481 Chapter 6 Miscellaneous 501 6.1 Shikimic Acid from Star Aniseed 503 6.2 Aleuritic Acid from Shellac 519 Answers to Questions and Translations -
(12) United States Patent (10) Patent No.: US 8,927.241 B2 Ajikumar Et Al
USOO8927241B2 (12) United States Patent (10) Patent No.: US 8,927.241 B2 Ajikumar et al. (45) Date of Patent: *Jan. 6, 2015 (54) MICROBIAL ENGINEERING FOR THE 2010/0297722 A1 11/2010 Anterola et al. PRODUCTION OF CHEMICAL AND 38: i h S. A. s3. Fi Sharks et al. PHARMACEUTICAL PRODUCTS FROM THE Jikumar et al. ISOPRENOID PATHWAY FOREIGN PATENT DOCUMENTS (75) Inventors: Parayil K. Ajikumar, Cambridge, MA WO WO97,385.71 A1 10, 1997 (US); Gregory Stephanopoulos, Int (US); Too Heng Phon, OTHER PUBLICATIONS 73) Assi : M h Insti fTechnol Broun et al., Catalytic plasticity of fatty acid modification enzymes (73) SS1gnees: C s t it's R nology, underlying chemical diversity of plant lipids. Science, 1998, vol. 282: ambridge, ; Nationa 1315-1317. liversity of Singapore, Singapore Chica et al., Semi-rational approaches to engineering enzyme activ (SG) ity: combining the benefits of directed evolution and rational design. (*) Notice: Subject to any disclaimer, the term of this Curr. Opi. Biotechnol.-- 200 5, vol. 16. 378RSRRSRA 384. sk atent is extended or adjusted under 35 Devos et al., Practical limits of function prediction. Proteins: Struc p S.C. 154(b) by 354 days ture, Function, and Genetics. 2000, vol. 41: 98-107. M YW- y yS. Kisselev L., Polypeptide release factors in prokaryotes and This patent is Subject to a terminal dis- eukaryotes: same function, different structure. Structure, 2002, vol. claimer. 10:8-9. Seffernicket al., Melamine deaminase and Atrazine chlorohydrolase: (21) Appl. No.: 13/249,388 98 percent identical but functionally different. J. Bacteriol., 2001, vol. 183 (8): 2405-2410.* (22) Filed: Sep.